Tirzepatide 10mg

Buy high-purity Tirzepatide 10mg in Australia. Third-party lab tested at >99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.

What is Tirzepatide? Tirzepatide (LY3298176) is a synthetic peptide studied as a dual agonist of the GIP and GLP-1 receptors, widely used as a reference compound in incretin and metabolic receptor research. Optic Labs supplies HPLC-tested Tirzepatide (>99% purity) as a lyophilised 10mg powder vial for laboratory research use only, dispatched Australia-wide from Sydney.

About Tirzepatide

Tirzepatide (LY3298176) is a synthetic peptide studied as a dual agonist of the GIP and GLP-1 receptors. As the first widely researched dual incretin receptor agonist, it is a common reference compound in incretin and metabolic receptor research, sitting between single agonists such as semaglutide and the triple agonist Retatrutide.

Optic Labs supplies Tirzepatide as a lyophilised (freeze-dried) powder in a sealed 10mg research vial, distributed Australian-domestic from Sydney, NSW. Every batch is independently HPLC tested, and the Certificate of Analysis is published in our COA library. The product is supplied strictly for laboratory research, development or analytical use, not for human or veterinary administration.

Product specifications

• Compound: Tirzepatide (LY3298176)
• Class: GIP / GLP-1 receptor dual agonist peptide
• Form: Lyophilised powder in sealed research vial
• Vial size: 10mg
• Purity: >99% (third-party HPLC, COA available)
• Storage (lyophilised): 2–8°C, protected from light
• Storage (reconstituted): 2–8°C, used within approximately 28 days
• Shipping: Australia-wide domestic dispatch from Sydney, NSW

Research background

• Receptor profile: Tirzepatide is studied for its activity at two incretin receptors (GIP and GLP-1) in a single molecule. Researchers often compare it with single GLP-1 agonists and with the GIP / GLP-1 / glucagon triple agonist Retatrutide.
• Research interest: it is a frequent subject in comparative receptor-pharmacology and metabolic-pathway studies.
• Handling: like most research peptides, it is supplied lyophilised for stability and reconstituted in bacteriostatic water for laboratory use.

Related reading: our Retatrutide triple agonist research guide. Related compounds: Retatrutide, Semaglutide, AOD-9604 and 5-Amino-1MQ.

Reconstitution and handling

Wipe the stopper with an alcohol swab, add bacteriostatic water slowly down the inside wall of the vial, and let the powder dissolve without shaking. Refrigerate at 2–8°C once reconstituted. Use our free peptide calculator for concentration maths, and see our reconstitution calculator guide and peptide storage guide.

Frequently asked questions

Where can I buy Tirzepatide in Australia?

Optic Labs supplies research-grade Tirzepatide 10mg from Sydney, NSW, with Australia-wide dispatch, AUD pricing and a published COA for every batch.

Is this the same as a prescription medicine?

No. Tirzepatide is the active ingredient in TGA-registered prescription medicines, which are only available through a doctor and pharmacy. The Optic Labs product is a research-grade compound supplied strictly for laboratory research. It is not a medicine and is not for human consumption. For background on how the TGA treats research peptides, see our peptide legality and TGA compliance guide.

What is the difference between Tirzepatide and Retatrutide?

Tirzepatide is studied as a dual GIP / GLP-1 receptor agonist, while Retatrutide is studied as a triple agonist that also acts at the glucagon receptor.

Is Tirzepatide tested?

Yes. Every batch is third-party HPLC tested, and the Certificate of Analysis is available in our COA library.

How should Tirzepatide be stored?

Keep lyophilised vials at 2–8°C away from light. Once reconstituted, keep refrigerated and use within approximately 28 days. Do not freeze reconstituted stock.

Where does Optic Labs ship to?

Optic Labs ships Australia-wide from Sydney, NSW. International shipping is not currently offered.

Legal disclaimer

All products on this site are supplied for laboratory research, development or analytical use only. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the Therapeutic Goods Administration (TGA) or the APVMA and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a compounding pharmacy or manufacturing facility as defined under the Therapeutic Goods Act 1989, and is not a registered provider of scheduled medicines or therapeutic goods.